Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG (T3 Pharma), a clinical stage Swiss biotech company, for an amount of up to 450 million CHF. T3 Pharma has …
Read Full Story at source (may require registration)
- How to Sell a Small Business: A Starter Guide for Business Owners - February 3, 2025
- European Shares Drift Lower Amid France’s Debt Woes - November 27, 2024
- FTSE 100 Modestly Higher In Cautious Trade - November 27, 2024